Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy
Journal of Cancer Research and Clinical Oncology · 2025
DOI: 10.1007/s00432-025-06159-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2025. Verfasst von Chen Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Southern Medical University, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Glioblastoma, Immunotherapy, Radiation Tolerance, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Projects in Guangzhou, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Southern Medical University, Guangzhou, 510515, China.
- Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Department of Radiation Oncology, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou, China.
- Southern Medical University, Guangzhou, 510515, China. renchen@smu.edu.cn.
- Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. renchen@smu.edu.cn.
- Department of Radiation Oncology, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou, China. renchen@smu.edu.cn.
Förderung
- Science and Technology Projects in Guangzhou
- National Natural Science Foundation of China
Zitieren
APA
Chen, C., Tan, P., Feng, W., Lei, Y., Hu, S., Xie, D., Liu, Y., Ren, C., & Du, S. (2025). Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-025-06159-0
Vancouver
Chen C, Tan P, Feng W, Lei Y, Hu S, Xie D, et al. Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy. Journal of Cancer Research and Clinical Oncology. 2025. doi:10.1007/s00432-025-06159-0
BibTeX
@article{Chen2025,
author = {Chen, Chen and Tan, Peixin and Feng, Wenqing and Lei, Yuan and Hu, Shushu and Xie, Dehuan and Liu, Yantan and Ren, Chen and Du, Shasha},
title = {Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2025},
doi = {10.1007/s00432-025-06159-0}
}
EUVIMED